13/09/2024
Exciting news in global health: WHO prequalifies first mpox vaccine! Bavarian Nordic’s MVA-BN vaccine now approved for worldwide use. Single-dose option and off-label use for children recommended in supply-constrained situations. This milestone enhances global mpox response, particularly in Africa where outbreaks persist. A significant step towards equitable vaccine access and improved public health preparedness.